Stanford V regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:Stanford V; Stanford V Regimen; Stanford V regimen
Overview
Overview
Stanford V regimen refers to a chemotherapy regimen consisting of mechlorethamine, doxorubicin hydrochloride, vinblastine, vincristine, bleomycin, etoposide and prednisone, administered on a compressed schedule and used in the treatment of Hodgkin lymphoma; it may be followed by consolidative radiation therapy.[1][2]
Regimen
Regimen
Mechlorethamine
Doxorubicin
Vinblastine
Vincristine
Bleomycin
Etoposide
Prednisone
References
References
- ↑ 1.0 1.1 Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A; et al. (2010). “Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience”. Ann Oncol. 21 (3): 574–81. doi:10.1093/annonc/mdp337. PMID 19759185.
- ↑ “NCI Thesaurus”.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH